Coronavirus Therapeutics Stock Comparison

Compare coronavirus therapeutics stocks. These companies are making significant advances in COVID-19 diagnostics and treatment. Get the most updated comparison by key indicators and discover each stock’s price target as well as recommendations by top Wall Street experts.
Compare up to 10 stocks

Comparison Results

Name
Price
Price Change
Price Target Upside
Market Cap
PE Ratio
Yearly Gain
Analyst Consensus
Follow
REGNRegeneron
$586.35
-0.53 (-0.09%)
$654.08
(11.55% Upside)
$62.47B
16.60
-8.01%
10Buy
4Hold
0Sell
Moderate Buy
GILDGilead Sciences
$69.02
0.37 (0.54%)
$79.10
(14.60% Upside)
$86.56B
286.00
-3.31%
7Buy
5Hold
0Sell
Moderate Buy
SRNESorrento Therapeutics
$8.32
-0.48 (-5.45%)
$30.00
(260.58% Upside)
$2.48B
-8.90
6.80%
1Buy
0Hold
0Sell
Moderate Buy
AMGNAmgen
$247.72
2.98 (1.22%)
$232.60
(-6.10% Downside)
$142.33B
20.30
0.42%
9Buy
7Hold
2Sell
Moderate Buy
ABBVAbbVie
$118.19
0.65 (0.55%)
$123.50
(4.49% Upside)
$208.75B
42.40
27.66%
9Buy
2Hold
0Sell
Strong Buy
GSKGlaxoSmithKline
$39.51
0.28 (0.71%)
$99.40B
13.70
2.17%
LLYEli Lilly & Co
$244.15
5.66 (2.37%)
$242.45
(-0.70% Downside)
$234.15B
36.50
54.97%
10Buy
2Hold
0Sell
Strong Buy

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Coronavirus Therapeutics Stocks Latest News

Read the latest stock news and analysis from the TipRanks news team.

Recent Analysts Ratings of Coronavirus Therapeutics Stocks

Name
Analyst
Analyst Firm
Rating
Price Target
Upside / Downside
Action
Date
REGNRegeneron Pharmaceuticals
premium
premium
Buy
premium
premium
Reiterated
AMGNAmgen Inc
premium
premium
Buy
premium
premium
Reiterated
SRNESorrento Therapeutics Inc
premium
premium
Buy
premium
premium
Reiterated
GILDGilead Sciences
premium
premium
Buy
premium
premium
Reiterated
LLYEli Lilly And Company
premium
premium
Buy
premium
premium
Reiterated
ABBVAbbvie
premium
premium
Buy
premium
premium
Reiterated
GSKGlaxoSmithKline
premium
premium
Hold
premium
premium
Reiterated
REGNRegeneron Pharmaceuticals
premium
premium
Hold
premium
premium
Reiterated
AMGNAmgen Inc
premium
premium
Buy
premium
premium
Reiterated
AMGNAmgen Inc
premium
premium
Buy
premium
premium
Reiterated

Most Recent Earnings of Coronavirus Therapeutics Stocks

SYMBOL
Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
REGNRegeneron
May 06, 2021
2021 (Q1)
8.69 / 10.09
5.43
85.86% (+4.66)
GILDGilead Sciences
Apr 29, 2021
2021 (Q1)
2.08 / 1.37
1.221
12.20% (+0.15)
SRNESorrento Therapeutics
May 05, 2021
2021 (Q1)
0.42 / <0.01
-0.357
102.24% (+0.36)
AMGNAmgen
Apr 27, 2021
2021 (Q1)
4.05 / 2.83
3.072
-7.78% (-0.24)
ABBVAbbVie
Apr 30, 2021
2021 (Q1)
2.81 / 1.99
2.019
-1.54% (-0.03)
GSKGlaxoSmithKline
Apr 28, 2021
2021 (Q1)
0.59 / 0.59
0.806
-26.43% (-0.21)
LLYEli Lilly & Co
Apr 27, 2021
2021 (Q1)
2.12 / 1.49
1.598
-7.07% (-0.11)

Coronavirus Therapeutics Stocks - FAQ

Which Coronavirus Therapeutics stocks have a "Strong Buy" analyst rating?
These Coronavirus Therapeutics stocks currently have a "Strong Buy" analyst rating consensus:
AbbVie - Strong Buy, based on 11 analyst ratings, 9 Buy, 2 Hold, and 0 Sell.
    Eli Lilly & Co - Strong Buy, based on 12 analyst ratings, 10 Buy, 2 Hold, and 0 Sell.
      Are Coronavirus Therapeutics stocks overpriced?
      Regeneron's stock price is currently $586.35, and its average 12-month price target is $654.08.
        Gilead Sciences's stock price is currently $69.02, and its average 12-month price target is $79.10.
          Sorrento Therapeutics's stock price is currently $8.32, and its average 12-month price target is $30.00.
            Amgen's stock price is currently $247.72, and its average 12-month price target is $232.60.
              AbbVie's stock price is currently $118.19, and its average 12-month price target is $123.50.
                GlaxoSmithKline's stock price is currently $39.51, and its average 12-month price target is N/A.
                  Eli Lilly & Co's stock price is currently $244.15, and its average 12-month price target is $242.45.
                    Which Coronavirus Therapeutics stocks pay dividends?
                    Regeneron does not currently pay dividends.
                      Gilead Sciences does not currently pay dividends.
                        Sorrento Therapeutics does not currently pay dividends.
                          Amgen does not currently pay dividends.
                            AbbVie does not currently pay dividends.
                              GlaxoSmithKline does not currently pay dividends.
                                Eli Lilly & Co currently pays a dividend of $0.85 which represents an annual dividend yield of 1.38%. Eli Lilly & Co's next Ex-dividend date is August 12, 2021 and its next payout date is September 10, 2021.